SCHEMBL379510

SCHEMBL379510

CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].[Ti+4].[Ti+4].[Ti+4].[Ti+4]

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29511758 1.00
SCHEMBL30577237 1.00 TSHR (0.33) TSHRALDH1A1HSD17B10LMNA
SCHEMBL3356662 1.00 TSHR (0.33) TSHRALDH1A1HSD17B10LMNA
SCHEMBL6756409 1.00 TSHR (0.33) TSHRALDH1A1HSD17B10LMNA
SCHEMBL7085 1.00 TSHR (0.33) TSHRALDH1A1HSD17B10LMNA
SCHEMBL23521060 0.94 ALDH1A1 (0.30) TSHRALDH1A1HSD17B10
Bromide SCHEMBL7024463 0.94 ALDH1A1 (0.30) TSHRALDH1A1HSD17B10
SCHEMBL19205418 0.94 ALDH1A1 (0.30) TSHRALDH1A1HSD17B10
SCHEMBL11504706 0.94 ALDH1A1 (0.30) TSHRALDH1A1HSD17B10
Bromide SCHEMBL7018789 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9234273-B2 Unsymmetrical ligand sources, reduced symmetry metal-containing compounds, and systems and methods including same MICRON TECHNOLOGY, INC. (US) 2016-01-12 US disclosed
EP-2290126-B1 Atomic layer deposition including metal beta-diketiminate compounds MICRON TECHNOLOGY INC (US) 2014-02-12 EP disclosed
US-8357784-B2 Beta-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same MICRON TECHNOLOGY, INC. (US) 2013-01-22 US disclosed
US-8188464-B2 Atomic layer deposition systems and methods including metal beta-diketiminate compounds MICRON TECHNOLOGY, INC. (US) 2012-05-29 US disclosed
EP-1907354-B1 UNSYMMETRICAL LIGAND SOURCES, REDUCED SYMMETRY METAL-CONTAINING COMPOUNDS, AND SYSTEMS AND METHODS INCLUDING SAME MICRON TECHNOLOGY INC (US) 2012-01-25 EP disclosed
US-20110301383-A1 Beta-Diketiminate Ligand Sources and Metal-Containing Compounds Thereof, and Systems and Methods Including Same MICRON TECHNOLOGY, INC. (US) 2011-12-08 US disclosed
US-8017184-B2 β-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same MICRON TECHNOLOGY, INC. (US) 2011-09-13 US disclosed
EP-1907600-B1 ATOMIC LAYER DEPOSITION USING ALKALINE EARTH METAL BETA-DIKETIMINATE PRECURSORS MICRON TECHNOLOGY INC (US) 2011-05-11 EP disclosed
US-20110071316-A1 Unsymmetrical Ligand Sources, Reduced Symmetry Metal-Containing Compounds, and Systems and Methods Including Same MICRON TECHNOLOGY, INC. (US) 2011-03-24 US disclosed
EP-2290126-A2 Atomic layer deposition systems and methods including metal beta-diketiminate compounds Micron Technology, INC. (US) 2011-03-02 EP disclosed
US-7416994-B2 Atomic layer deposition systems and methods including metal beta-diketiminate compounds MICRON TECHNOLOGY, INC. (US) 2008-08-26 US disclosed
EP-1911074-A2 BETA-DIKETIMINATE LIGAND SOURCES AND METAL-CONTAINING COMPOUNDS THEREOF, AND SYSTEMS AND METHODS INCLUDING SAME MICRON TECHNOLOGY, INC. (US) 2008-04-16 EP disclosed
EP-1907600-A2 ATOMIC LAYER DEPOSITION SYSTEMS AND METHODS INCLUDING METAL BETA-DIKETIMINATE COMPOUNDS Micron Technology, Inc. (US) 2008-04-09 EP disclosed
EP-1907354-A2 UNSYMMETRICAL LIGAND SOURCES, REDUCED SYMMETRY METAL-CONTAINING COMPOUNDS, AND SYSTEMS AND METHODS INCLUDING SAME MICRON TECHNOLOGY, INC. (US) 2008-04-09 EP disclosed
WO-2007002674-A2 UNSYMMETRICAL LIGAND SOURCES, REDUCED SYMMETRY METAL-CONTAINING COMPOUNDS, AND SYSTEMS AND METHODS INCLUDING SAME MICRON TECHNOLOGY, INC. (US) 2007-01-04 WO disclosed
WO-2007002672-A2 ATOMIC LAYER DEPOSITION USING ALKALINE EARTH METAL BETA-DIKETIMINATE PRECURSORS MICRON TECHNOLOGY, INC. (US) 2007-01-04 WO disclosed
WO-2007002673-A2 BETA-DIKETIMINATE LIGAND SOURCES AND METAL-CONTAINING COMPOUNDS THEREOF, AND SYSTEMS AND METHODS INCLUDING SAME MICRON TECHNOLOGY, INC. (US) 2007-01-04 WO disclosed
US-20060292303-A1 Beta-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same MICRON TECHNOLOGY, INC. (US) 2006-12-28 US disclosed
US-20060292841-A1 Atomic layer deposition systems and methods including metal beta-diketiminate compounds MICRON TECHNOLOGY, INC. (US) 2006-12-28 US disclosed
US-20060292873-A1 Unsymmetrical ligand sources, reduced symmetry metal-containing compounds, and systems and methods including same MICRON TECHNOLOGY, INC. (US) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060292303-A1 Beta-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same PBK, ZKSCAN2, DEK TSHR 4395/4885ALDH1A1 212/4885HSD17B10 721/4885
US-20110071316-A1 Unsymmetrical Ligand Sources, Reduced Symmetry Metal-Containing Compounds, and Systems and Methods Including Same TESK1, VDAC1, KARS1 TSHR 4754/4885ALDH1A1 1307/4885HSD17B10 356/4885
US-20110301383-A1 Beta-Diketiminate Ligand Sources and Metal-Containing Compounds Thereof, and Systems and Methods Including Same PBK, ZKSCAN2, DEK TSHR 4395/4885ALDH1A1 212/4885HSD17B10 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.